Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic

In the coming decades, a massive shift in the aging segment of the population will have major social and economic consequences around the world. One way to offset this increase is to expedite the development of geroprotectors, substances that slow aging, repair age‐associated damage and extend healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Moskalev, Alexey, Chernyagina, Elizaveta, Tsvetkov, Vasily, Fedintsev, Alexander, Shaposhnikov, Mikhail, Krut'ko, Vyacheslav, Zhavoronkov, Alex, Kennedy, Brian K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854916/
https://www.ncbi.nlm.nih.gov/pubmed/26970234
http://dx.doi.org/10.1111/acel.12463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854916/
https://www.ncbi.nlm.nih.gov/pubmed/26970234
http://dx.doi.org/10.1111/acel.12463

Ejemplares similares